REDHAWK
SUCCESSFULLY
COMPLETES INDEPENDENT
TESTING OF SANDD
PRO™ FOR IEC AND UL
CERTIFICATION
Sales Launch Expected in Summer 2020
LAFAYETTE,
LA -- May
07, 2020 --
InvestorsHub NewsWire
-- RedHawk
Holdings Corp.
(OTC:
SNDD) ("RedHawk" or the
"Company"), a diversified holding company primarily engaged in sales and
distribution
of medical devices, announced today
that it
has
successfully
completed the independent laboratory testing of its newly designed
SANDD
Pro™
needle incineration
device. Testing was
performed by
Intertek PLC ("Intertek") to independently confirm the
SANDD
Pro™
meets the
safety
requirements
of both International Electrotechnical
Commission 61010-1 and Underwriter Laboratories
61010-1
for the United States, Canada and Europe; Certification Bodies
Scheme
for the
United
States,
Canada and Europe; and,
Electrical Testing
Laboratories Listing for the United
States and
Canada.
Intertek is
a leading
total quality assurance provider to industries worldwide
with more than
46,000 employees in 1,000 locations in over 100
countries
based in the
UK.
Intertek testing
ensures products meet
quality, health, environmental, safety, and social
accountability standards for virtually any market around the world.
Intertek holds extensive
world-wide
accreditations and recognitions.
"The
successful independent lab testing of our newly designed
SANDD
Pro™
needle incineration
unit was the final
step before commencing production," commented G. Darcy Klug,
RedHawk's Chairman and Interim Chief Executive
Officer. "We can now begin the production process and we expect to launch sales and leasing of the
SANDD
Pro™
needle
incineration device, coupled with certain
bio-hazard waste disposal services,
during
the summer of 2020."
The
SANDD
Pro™ is
capable of incinerating hypodermic
needles 18-gauge and higher, up to 8 inch in
length. The
SANDD Pro™
technology also features a separate portable, rechargeable,
lithium-ion
battery operated
unit (the
"SANDD Pro™ - Portable")
capable of
incinerating as many as 300 needles,
ranging in
gauges as thick as 21 gauge and lengths
up to 8" on a
single charge. RedHawk believes the
SANDD Pro™
- Portable will be ideal for field use by
first
responders, home health care nurses,
veterinarians and home use injectors. The
SANDD Pro™
is both FDA approved and OSHA
compliant.
# # #
About RedHawk Holdings Corp.
RedHawk Holdings Corp.,
formerly Independence Energy Corp., is a
diversified holding company
which, through its
subsidiaries, is engaged in the sales
and distribution of medical
devices, sales of
branded generic pharmaceutical
drugs, commercial real estate
investment and leasing,
sales of point of entry full-body
security systems, and specialized
financial
services. Through its
medical products business
unit, the Company sells
the Sharps and Needle
Destruction Device
(SANDD™), WoundClot
Surgical - Advanced Bleeding
Control, and the
Carotid Artery Digital
Non-Contact Thermometer. Through our
United Kingdom based
subsidiary, we manufacture and market
branded generic
pharmaceuticals. RedHawk
Energy holds the exclusive U.S.
manufacturing and distribution rights
for the Centri
Controlled Entry System, a
unique, closed cabinet, nominal dose transmission
full-body x-ray
scanner. For more information,
please visit: http://www.redhawkholdingscorp.com
Cautionary Statement Regarding
Forward-Looking
Statements
This release may contain forward-looking
statements. Forward-looking
statements are all statements other
than statements of historical fact.
Statements contained in this
release that are not
historical facts may be deemed
to be
forward-looking
statements. The words "anticipate," "may,"
"can," "plans," "believes,"
"estimates," "expects," "projects,"
"targets," "intends," "likely,"
"will," "should," "to be," "potential" and
any similar expressions are
intended to identify those
assertions as
forward-looking statements.
Investors are cautioned that
forward-looking statements are
inherently uncertain. Actual
performance and results may
differ materially from that projected or
suggested herein due to
certain risks and
uncertainties, including risks and
uncertainties related to economic conditions and
changes in market conditions. In
evaluating
forward-looking statements, you should
consider the various factors
which may cause actual
results to differ materially
from any forward-looking statements
including those listed in the
"Risk Factors" section of
our latest 10-K report.
Further, the
Company may make changes to
its business plans that could or will affect
its results. Investors are
cautioned that the Company
will undertake no obligation to update
any forward-looking
statements.
Company
Contact:
G. Darcy
Klug, Chairman,
CEO and CFO
(337)
269-5933
darcy.klug@redhawkholdingscorp.com
Investor
Relations:
Stephanie
Prince, Managing Director
PCG Advisory
(646) 762-4518
sprince@pcgadvisory.com
Media
Contact:
Valerie
Allen
Valerie Allen
Public Relations
(310)
382-7800
valerie@valerieallenpr.com
RedHawk (CE) (USOTC:SNDD)
Graphique Historique de l'Action
De Mai 2024 à Juin 2024
RedHawk (CE) (USOTC:SNDD)
Graphique Historique de l'Action
De Juin 2023 à Juin 2024